These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 15958518

  • 21. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE, Shin JS, Leem DG, Kim SD, Cho WJ, Lee KT.
    Chem Biol Interact; 2016 Dec 25; 260():196-207. PubMed ID: 27720946
    [Abstract] [Full Text] [Related]

  • 22. Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines.
    Adler S, Rashid G, Klein A.
    Anticancer Res; 2011 Nov 25; 31(11):3733-7. PubMed ID: 22110194
    [Abstract] [Full Text] [Related]

  • 23. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K, Liu H, Kim S, Guo M, Navarro V, Bander NH.
    Prostate; 2009 Oct 01; 69(14):1579-85. PubMed ID: 19575420
    [Abstract] [Full Text] [Related]

  • 24. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
    Ikezoe T, Chen SS, Yang Y, Heber D, Taguchi H, Koeffler HP.
    Int J Oncol; 2003 Nov 01; 23(5):1461-70. PubMed ID: 14532991
    [Abstract] [Full Text] [Related]

  • 25. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
    Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH.
    J Androl; 2008 Nov 01; 29(6):661-8. PubMed ID: 18676361
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C, Chen Z, Hu X, Wang L, Li C, Xue J, Zhang P, Chen W, Jiang A.
    Mol Med Rep; 2015 Jun 01; 11(6):4625-32. PubMed ID: 25673182
    [Abstract] [Full Text] [Related]

  • 27. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
    Bhattacharyya RS, Krishnan AV, Swami S, Feldman D.
    Mol Cancer Ther; 2006 Jun 01; 5(6):1539-49. PubMed ID: 16818513
    [Abstract] [Full Text] [Related]

  • 28. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
    Dai JL, Maiorino CA, Gkonos PJ, Burnstein KL.
    Steroids; 1996 Sep 01; 61(9):531-9. PubMed ID: 8883219
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter.
    Cram EJ, Liu BD, Bjeldanes LF, Firestone GL.
    J Biol Chem; 2001 Jun 22; 276(25):22332-40. PubMed ID: 11297539
    [Abstract] [Full Text] [Related]

  • 33. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH.
    Cancer Res; 2006 Oct 15; 66(20):10064-72. PubMed ID: 17047070
    [Abstract] [Full Text] [Related]

  • 34. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL, Lin JK.
    Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333
    [Abstract] [Full Text] [Related]

  • 35. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW.
    Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539
    [Abstract] [Full Text] [Related]

  • 36. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A, Sallami S, Céraline J, Oueslati R.
    Cell Biol Int; 2013 May 01; 37(5):464-70. PubMed ID: 23418075
    [Abstract] [Full Text] [Related]

  • 37. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
    Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA.
    Mol Cancer Res; 2003 Mar 01; 1(5):385-92. PubMed ID: 12651911
    [Abstract] [Full Text] [Related]

  • 38. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.
    Singh-Gupta V, Banerjee S, Yunker CK, Rakowski JT, Joiner MC, Konski AA, Sarkar FH, Hillman GG.
    Cancer Lett; 2012 May 01; 318(1):86-92. PubMed ID: 22155105
    [Abstract] [Full Text] [Related]

  • 39. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.